Utah Medical Products, Inc.UTMDNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank7
3Y CAGR-18.6%
5Y CAGR-10.7%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
-18.6%/yr
vs +5.5%/yr prior
5Y CAGR
-10.7%/yr
Recent deceleration
Acceleration
-24.1pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.95M | -25.0% |
| 2024 | $14.60M | -32.6% |
| 2023 | $21.64M | +6.5% |
| 2022 | $20.33M | -1.6% |
| 2021 | $20.65M | +7.1% |
| 2020 | $19.28M | +529.9% |
| 2019 | $-4.48M | -127.3% |
| 2018 | $16.43M | +7.3% |
| 2017 | $15.31M | +36.4% |
| 2016 | $11.23M | - |